Biofilm formation is a major virulence attribute of Candida albicans and is directly associated with therapeutic failure. One method by which Candida acquires antifungal resistance is the expression of drug-resistance genes. This study aimed to evaluate the transcriptional regulation of several genes associated with antifungal resistance of C. albicans under planktonic, recently adhered and biofilm growth modes and in C. albicans biofilms in response to antifungal agents. Initially, the antifungal susceptibility of C. albicans cultures in different growth modes was evaluated by standard antifungal susceptibility testing. Next, to assess CDR1, CDR2, MDR1, ERG11, FKS1 and PIL1 expression, RNA was harvested from cells in each growth mode, and from biofilms after drug treatment, and subjected to quantitative real-time RT-PCR (qRT-PCR). Biofilm C. albicans was more resistant to antifungals than recently adhered cells and stationaryphase planktonic cultures. Transcriptional expression of CDR1, CDR2, MDR1, ERG11 and FKS1 was lower in recently adhered C. albicans than in the stationary-phase planktonic cultures. In contrast, PIL1 levels were significantly increased in recently adhered and biofilm modes of growth. The expression of MDR1 in biofilms greatly increased on challenge with amphotericin B but not with the other drugs tested (P,0.01). ERG11 was significantly upregulated by ketoconazole (P,0.01). Caspofungin and amphotericin B significantly upregulated FKS1 expression, whereas they significantly downregulated PIL1 expression (P,0.01). These results indicate that the expression of drug-resistance genes is associated with higher drug resistance of Candida biofilms, and lay a foundation for future large-scale genome-wide expression analysis.
INTRODUCTION
Candida albicans is the major fungal pathogen causing infections in humans, ranging from superficial mucosal infection to systemic mycoses (Samaranayake & MacFarlane, 1990) . Candidal infections rank as the third or fourth leading cause of hospital-acquired infection in the USA and are associated with high morbidity and mortality rates (Pfaller & Diekema, 2007) . The ability of free-floating (planktonic) cells to exhibit an attached biofilm mode of growth is a major virulence attribute of Candida species and a direct cause of therapeutic failure (Tumbarello et al., 2007) . As with other microbial biofilms, a key phenotypic feature of Candida biofilms is their high degree of drug resistance (Seneviratne et al., 2008a) . Therefore, a thorough understanding of Candida biofilm properties is of great clinical importance.
In general, four classes of antifungal drugs are used to manage fungal infections, namely polyenes, azoles, fluoropyrimidines and echinocandins (Ruhnke et al., 2008) . One mechanism by which C. albicans acquires increased antifungal resistance is the expression of drug-resistance genes. For instance, the expression of genes regulating drug efflux pumps, which expel a wide range of toxic metabolites and drugs out of cells, is associated with increased drug resistance against azole antifungals in the planktonic mode of C. albicans (Prasad & Kapoor, 2004) . Acquired drug resistance in Candida is related to ATP-binding cassette transporters encoded by the Candida drug-resistance genes CDR1 and CDR2, as well as major facilitator transporters encoded by the multidrug-resistance gene MDR1 (Nakamura et al., 2001) . Resistance of C. albicans against azole antifungals is associated with overexpression or mutation of ERG11, which encodes 14-a-demethylase in the ergosterol biosynthesis pathway. In contrast, echinocandins are poor substrates for multidrug efflux transporters, and resistance is commonly associated with point mutations or overexpression of the FKS1 gene (Nett et al., 2010 confined to the planktonic mode of growth, and few data are available for the biofilm mode (Franz et al., 1998 (Franz et al., , 1999 Holmes et al., 2008; Lopez-Ribot et al., 1998; Perea et al., 2001; Sanglard et al., 1995; White, 1997) . Therefore, we aimed to study the influence of mode of growth (planktonic, adhesion and biofilm) on the transcriptional expression of several genes that are associated with drug resistance in C. albicans. In addition, we included the PIL1 gene, which encodes the hyphal-specific echinocandin-binding protein (Pil1p), as we found previously that Pil1p is significantly upregulated in Candida biofilms and have proposed it as a possible drug target against Candida biofilms (Seneviratne et al., 2008c) . In the present study, we also tested the response of C. albicans biofilms to three classes of antifungals, namely azoles, polyenes and echinocandins.
METHODS
Organisms and culture conditions. C. albicans strain SC5314, which is well characterized and has been used in our previous studies (Jayatilake et al., 2007; Lu et al., 2006) , was subcultured on Sabouraud dextrose agar (SDA; Gibco) and maintained at 4 uC during the experimental period. The purity of the cultures was confirmed periodically by Gram staining and the use of commercially available carbohydrate assimilation tests (API 32C identification system; bioMérieux).
Preparation of Candida cultures in recently adhered, biofilm and planktonic modes. Candida cultures in the different modes of growth were prepared according to a previously published protocol (Jin et al., 2004) . In brief, Candida cells were grown in SDA medium at 37 uC for 18 h. A loopful of yeast was inoculated into a flask of yeast nitrogen base (YNB; Difco) medium supplemented with 50 mM glucose and incubated in a rotary shaker at 75 r.p.m. overnight. Cells were washed twice with 20 ml PBS (0.1 M, pH 7.2) and resuspended in YNB supplemented with 100 mM glucose until it reached an OD 520 of 0.38 (1610 7 cells ml 21 ). This standard cell suspension was used to obtain recently adhered, biofilm and stationary-phase planktonic cultures. First, 100 ml suspension was placed into each well of a 96-well microtitre plate and incubated for 90 min at 37 uC in a shaker at 75 r.p.m. to allow yeast adherence to the well surface. The growth medium was aspirated and each well was washed with PBS to remove loosely adherent cells, leaving cells in the 'recently adhered mode' of growth, to which YNB containing 100 mM glucose was added. Plates were then incubated at 37 uC in a shaker at 75 r.p.m. for 24 h to obtain cultures in biofilm mode. A portion of the standard cell suspension was incubated under identical conditions for 24 h to obtain stationary-phase planktonic cultures. Stationary-phase planktonic cultures reached a concentration of approximately 10 8 cells ml 21 by 24 h and were considered to be high-density planktonic cultures. For each growth phase, microscopic examination of the cultures was performed to rule out contamination.
Antifungal susceptibility testing of stationary-phase planktonic, recently adhered and biofilm cultures. The commonly used antifungal agents amphotericin B, caspofungin and ketoconazole, belonging to the polyene, echinocandin and azole classes of antifungals, respectively, were used in this study. The antifungal agents were prepared as described previously (Ellepola & Samaranayake, 2001 ). In brief, stock solutions of each drug were serially diluted with RPMI 1640 (Life Technologies) supplemented with 2 % glucose to obtain drug concentrations ranging from 480 to 0.225 mg ml 21 for amphotericin B, 100 to 0.1 mg ml 21 for caspofungin and 64 to 0.125 mg ml 21 for ketoconazole. Antifungal susceptibility testing was performed using an XTT reduction assay, as described previously (Seneviratne et al., 2008b) . In brief, 24 h Candida biofilms were washed with 100 ml PBS to remove non-adherent cells. Each drug solution (100 ml) was added to the microtitre plate containing Candida biofilms. Biofilms were then incubated at 37 uC for 24 h with the antifungals and the metabolic activity of the fungal cells was determined by XTT assay. XTT (Sigma) solution (1 mg ml 21 in PBS) was prepared, filter-sterilized through a 0.22 mm pore size filter and stored at 270 uC. Menadione (Sigma) solution (0.4 mM) was prepared and filter-sterilized immediately before each assay. Prior to each assay, XTT solution was thawed and mixed with the menadione solution at a ratio of 5 : 1 by volume. The biofilms were first washed with 200 ml PBS, and then 200 ml XTT solution (PBS : XTT : menadione at 158 : 40 : 2) was added to each of the pre-washed wells and the control wells. High-density planktonic cultures exposed to antifungals in microtitre plates were mixed directly with 200 ml XTT solution, as described in previous studies (Seneviratne et al., 2008b) . Microtitre plates with biofilm and high-density planktonic cultures were then incubated in the dark for 3 h at 37 uC. Following incubation, 100 ml solution was transferred to new wells and the colour change in the solution was measured with a microtitre plate reader (SpectraMAX 340 Tunable Microplate Reader; Molecular Devices) at 490 nm. The MIC value was defined as the lowest drug concentration with a 50 % reduction in opacity (MIC 50 ) compared with the drug-free control. Each experiment was repeated three times.
Transcriptional regulation of drug-resistance genes. To study the transcriptional regulation of genes associated with drug resistance in C. albicans (CDR1, CDR2, MDR1, ERG11, FKS1 and PIL1), we cultured cells in recently adhered and biofilm modes as described above but in polystyrene six-well plates instead of in 96-well plates (Seneviratne et al., 2008c) . Adhered Candida cells were collected from six-well plates after 1.5 h (recently adhered mode) and 24 h (biofilm mode), washed with PBS and processed for RNA extraction. In parallel, 24 h stationary-phase planktonic cultures of C. albicans were harvested and total RNA was obtained. We also examined transcriptional regulation in 24 h C. albicans biofilms in response to antifungal treatment. Candida biofilms were incubated for 24 h with subMIC concentrations of antifungals (1.88 mg amphotericin B ml 21 , 20 mg caspofungin ml 21 and 32 mg ketoconazole ml 21 ). Cells were then washed with PBS and processed for RNA extraction.
RNA extraction, cDNA synthesis and quantitative real-time PCR. Total RNA was extracted from Candida cultures using the SV Total RNA isolation system (Promega) according to the manufacturer's instructions (Samaranayake et al., 2005) . RNA purity and integrity were determined with a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies). Additionally, gel electrophoresis was performed to verify that the RNA was intact. cDNA was synthesized from 2 mg total RNA using oligo(dT) primers and Superscript III reverse transcriptase (Invitrogen), as described previously (Seneviratne et al., 2008c) . For quantitative analysis of gene expression, the mRNA level was measured using quantitative real-time RT-PCR (qRT-PCR). The primers (Sigma-Aldrich) used in this assay are listed in Table 1. qRT-PCR was carried out using an ABI PRISM 7900HT (Applied Biosystems) sequence detection system using SYBR Green incorporation (SYBR Green PCR Master Mix; Applied Biosystems) in duplicate for at least three separate experiments. Twenty microlitres of PCR mix (10 ml SYBR PCR Master Mix, 1 ml cDNA, 2 ml primer mix and 7 ml double-distilled water) was used for each gene and qRT-PCR was performed using the following cycling conditions: 95 uC for 5 min, followed by 40 cycles of 95 uC for 15 s and 60 uC for 30 s. Fluorescence intensities were quantified using StepOne software (Applied Biosystems). The relative quantities of the target genes were normalized against ACT1 housekeeping gene expression and analysed using the comparative DDC t method, taking the amplification efficiency into consideration (Pfaffl, 2001 ). Groups were compared by analysis of variance with the significance level set at P,0.01.
RESULTS

Antifungal susceptibility testing
Biofilm C. albicans cultures were generally more resistant to antifungals than recently adhered cells and stationary-phase, high-density planktonic cultures (Table 2 ), as reported in previous studies (Baillie & Douglas, 1999; Chandra et al., 2001; Seneviratne et al., 2008b) . However, all cultures, including stationary-phase, high-density planktonic cultures, were resistant to ketoconazole. This is in agreement with previous studies on the dose-dependent response of fungistatic drugs (Seneviratne et al., 2008b; Beggs, 1989) .
Transcriptional expression of drug resistanceassociated genes in different growth modes
Transcriptional expression of CDR1, CDR2, MDR1, ERG11 and FKS1 was lower in recently adhered C. albicans cultures than in stationary-phase planktonic cultures (Fig.  1a-e) . In contrast, expression of PIL1 was significantly increased in recently adhered cells ( Fig. 1f ; P,0.01). There was no significant difference between stationary-phase cultures and biofilm cultures in terms of expression of CDR1, CDR2, MDR1, FKS1 and ERG11. Interestingly, expression of PIL1 was significantly higher in the biofilm cultures than in the planktonic cultures (P,0.01).
Transcriptional regulation of drug resistanceassociated genes in Candida biofilms in response to antifungals Expression of CDR1 was not significantly altered when biofilms were challenged with antifungal agents (Fig. 2a) . CDR2 expression increased significantly on caspofungin challenge (Fig. 2b) . Interestingly, MDR1 expression was greatly increased on amphotericin B challenge but not with other drugs (Fig. 2c) . Caspofungin and amphotericin B significantly increased the expression of FKS1 ( Fig. 2d ; P,0.01). Caspofungin upregulated FKS1 expression to a greater extent than ketoconazole and amphotericin B, but the difference was not statistically significant (P.0.05). Of all the antifungals tested, only ketoconazole significantly upregulated ERG11 expression ( Fig. 2e ; P,0.01). In contrast, amphotericin B and caspofungin significantly downregulated PIL1 expression ( Fig. 2f ; P,0.01).
DISCUSSION
C. albicans is the major fungal pathogen of humans (Navarro-García et al., 2001) . In recent years, Candida infections have increased disproportionately as a result of the increased number of compromised host populations, such as patients with AIDS, diabetes and various cancers, and organ-transplant recipients (Beck-Sagué et al., 1993; Wisplinghoff et al., 2004) . The number of drug-resistant Candida strains has also increased dramatically owing to the increased use of antifungal agents. The expression of drug-resistance genes as a mechanism by which Candida acquires drug resistance is a well-known phenomenon in the planktonic mode of growth of this fungus. In the present study, we examined the transcriptional regulation of a subset of drug-resistance genes associated with drug resistance in C. albicans under various growth modes and when biofilms were exposed to antifungals.
We found that adhered cells of C. albicans were more resistant to antifungals than stationary-phase, high-density planktonic cultures, and resistance increased further after the formation of biofilms. This phenomenon has been Regulation of drug-resistance genes in Candida biofilms observed by various research groups, including ourselves (Mateus et al., 2004; Seneviratne et al., 2008b) . However, levels of expression of the drug efflux pump-related genes CDR1, CDR2 and MDR1 were significantly lower in adhered cells than in planktonic cultures. Therefore, it is unlikely that efflux pump-related genes play a major role in Fig. 1 . Relative transcriptional expression of drug-resistance genes in different growth modes of C. albicans. Results were normalized against ACT1 housekeeping gene expression, which was assigned a value of 1, and are shown as means±SD of three independent experiments. *, P,0.01. Fig. 2 . Relative transcriptional expression of drug-resistance genes in C. albicans biofilms in response to antifungal agents. Results were normalized against ACT1 housekeeping gene expression, which was assigned a value of 1, and are shown as means±SD of three independent experiments. AMB, Amphotericin B; KTC, ketoconazole; CAS, caspofungin. *, P,0.01.
adhesion-conferred drug resistance of C. albicans. Our results are in agreement with those of other studies, which found that multidrug efflux pumps have a relatively minor role in the mechanism of resistance of C. albicans biofilms against fluconazole, an azole drug (Mukherjee et al., 2003; Ramage et al., 2002) . However, our study demonstrates the minor involvement of efflux pumps in resistance to polyene and echinocandin classes of drugs. Mukherjee et al. (2003) observed that sterol composition, particularly ergosterol, is significantly decreased in the late phase of C. albicans biofilm formation. Thus, they proposed that a reduction in membrane ergosterol composition or its replacement by other types of sterols, such as lanosterol, contributes to the reduced susceptibility to azoles and polyenes. Azole resistance of C. albicans has also been shown to be associated with increased expression of ERG11 (Lupetti et al., 2002; Morschhäuser, 2002) . Some authors have also suggested that increased expression of ERG11 in the presence of an azole could be a feedback mechanism to compensate for the reduced ergosterol content. Our study showed that ERG11 expression in biofilms is significantly upregulated on challenge with ketoconazole but not with other antifungals. Therefore, we speculate that ERG11 might play a role in the azole resistance of C. albicans biofilms but not with other classes of drugs.
The glucan synthase gene FKS1, which encodes 1,3-b-Dglucan, is associated with resistance to amphotericin B and anidulafungin in Candida biofilms (Nett et al., 2010) . We noted that FKS1 expression was significantly upregulated after treatment of C. albicans biofilms with amphotericin B and caspofungin. Therefore, it is conceivable that these biofilms rapidly increase glucan synthesis in response to noxious environmental stress exerted by antifungal agents. It is also known that point mutations or hot spots in the FKS1 gene may cause higher-order resistance, although some studies have presented conflicting evidence (Walker et al., 2010) . This is a novel area that could be explored further to understand the mechanism of higher-order drug resistance in C. albicans biofilms.
PIL1 expression was significantly reduced on challenge with caspofungin and amphotericin B. It has been proposed that PIL1 is associated with b-1,3-glucan synthase and plays a role in its regulation (Edlind & Katiyar, 2004) . A protein complex containing both Pil1p and Fks1p proteins has been identified (Gavin et al., 2002) . Therefore, our results suggest that Pil1p and Fks1p have opposing effects on the regulation of glucan synthesis, particularly in response to caspofungin and amphotericin B. At present, we are in the process of generating and characterizing PIL1 mutants. Understanding the roles of PIL1 and FKS1 may have implications in developing and modifying echinocandin-based regimens to eliminate C. albicans biofilms more efficiently.
Finally, MDR1 expression increased significantly when Candida biofilms were treated with amphotericin B. Because the amphotericin B molecule is too large for drug efflux pumps to expel it, increased MDR1 expression is unlikely to result in increased expulsion of this antifungal out of the cell. Amphotericin B kills fungi by acting on ergosterol in the fungal cell membrane to increase membrane permeability (Vanden Bossche et al., 1994) . In addition to this primary action, amphotericin B exerts oxidative stress on the fungal cells (Brajtburg et al., 1990; Ellis, 2002; Vanden Bossche et al., 1994) . It is known that upregulation of the MDR1 gene is influenced by two regulatory elements: the hydrogen peroxide-responsive element and the benomylresponsive element (Rognon et al., 2006) . Therefore, it is possible that increased expression of MDR1 is a consequence of oxidative damage induced by amphotericin B, perhaps as part of an oxidative defence system for protecting cells. This possible mechanism is supported by the fact that expression of MDR1 was not significantly altered by the other two drugs, caspofungin and ketoconazole, which do not cause oxidative damage to fungal cells. MDR1 overexpression has been linked to oxidative resistance in C. albicans (Kusch et al., 2004) . We propose that an increase in MDR1 expression in Candida biofilms is a protective response to oxidative damage caused by amphotericin B but is not necessarily a resistance mechanism.
In conclusion, resistance of C. albicans biofilms to different classes of antifungals seems to be associated with transcriptional regulation of different drug-resistance genes. The data presented here shed some new light on drug resistance in C. albicans biofilms and lay a foundation for future large-scale genome-wide expression analysis.
